bioAffinity Technologies, Inc. (BIAF)
USD 1.04
(1.96%)
USD 1.04
(1.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -6.03 Million | -4.07 Million | -2.04 Million | -2.2 Million | -2.49 Million |
| Net Income | -7.93 Million | -8.15 Million | -6.32 Million | -7.26 Million | -3.3 Million |
| Depreciation & Amortization | 249.59 Thousand | 10.18 Thousand | 4817.00 | 22.24 Thousand | 40.27 Thousand |
| Deferred income taxes | -964.08 Thousand | - | 3.84 Million | - | - |
| Stock-based compensation | 748.82 Thousand | 248.59 Thousand | 43.01 Thousand | 275.73 Thousand | - |
| Change in working capital | 900.79 Thousand | 114.2 Thousand | 632.82 Thousand | 482.62 Thousand | 322.01 Thousand |
| Other non-cash items | 964.08 Thousand | 3.71 Million | -244.35 Thousand | 4.28 Million | 575.1 Thousand |
| Investing Cash Flow | -2.2 Million | -219.98 Thousand | - | -2888.00 | -11.39 Thousand |
| Investments in PPE | -22.9 Thousand | -219.98 Thousand | - | -2888.00 | -11.39 Thousand |
| Acquisitions | -2.18 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -2.2 Million | - | - | - | - |
| Financing Cash Flow | -344.98 Thousand | 14.34 Million | 3.32 Million | 1.71 Million | 2.33 Million |
| Debt repayment | -344.98 Thousand | -694.98 Thousand | -3.5 Million | -1.71 Million | -2.33 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | -185.00 | - | - | - |
| Common Stock Issuance | - | 6.02 Million | - | - | - |
| Other Financing Activities | -344.98 Thousand | 9.01 Million | 6.83 Million | 3.43 Million | - |
| Accounts receivables | 311.36 Thousand | -8959.00 | - | - | 290.00 |
| Accounts payables | -14.5 Thousand | 114.63 Thousand | 39.02 Thousand | 87.96 Thousand | -39.82 Thousand |
| Inventory | -12.94 Thousand | -5540.00 | - | - | - |
| Other working capital | 616.86 Thousand | 14.06 Thousand | 593.8 Thousand | 394.65 Thousand | 361.54 Thousand |
| Cash at beginning of period | 11.41 Million | 1.36 Million | 83.1 Thousand | 578.48 Thousand | 745.07 Thousand |
| Cash at end of period | 2.82 Million | 11.41 Million | 1.36 Million | 83.1 Thousand | 578.48 Thousand |
| Capital Expenditure | -22.9 Thousand | -219.98 Thousand | - | -2888.00 | -11.39 Thousand |
| Effect of forex changes on cash | 10.00 | - | - | - | - |
| Net cash flow / Change in cash | -8.59 Million | 10.05 Million | 1.27 Million | -495.37 Thousand | -166.59 Thousand |
| Free Cash Flow | -6.06 Million | -4.29 Million | -2.04 Million | -2.21 Million | -2.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.11 Million | -1.96 Million | -7.93 Million | -2.37 Million | -2.29 Million | -1.74 Million |
| Depreciation & Amortization | 151.07 Thousand | 149.63 Thousand | 249.59 Thousand | 148.78 Thousand | 57.56 Thousand | 21.55 Thousand |
| Deferred income taxes | - | - | -964.08 Thousand | -722.47 Thousand | -4.84 Billion | 170.25 Million |
| Stock-based compensation | 286.19 Thousand | 283.71 Thousand | 748.82 Thousand | 234.51 Thousand | 186.44 Thousand | 170.25 Thousand |
| Change in working capital | 140.58 Thousand | -817.5 Thousand | 900.79 Thousand | 373.56 Thousand | 514.35 Thousand | 188.41 Thousand |
| Other non-cash items | 616.52 Thousand | 1.1 Million | 964.08 Thousand | 722.47 Thousand | 4.84 Billion | -170.25 Million |
| Investing Cash Flow | -28.28 Thousand | -41.38 Thousand | -2.2 Million | 13.44 Thousand | -2.18 Million | -3861.00 |
| Investments in PPE | -28.28 Thousand | -41.38 Thousand | -22.9 Thousand | 13.44 Thousand | -169.00 | -3861.00 |
| Acquisitions | - | - | -2.18 Million | 2.18 Million | -2.18 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -2.2 Million | -2.2 Million | - | - |
| Financing Cash Flow | -91.14 Thousand | 2.01 Million | -344.98 Thousand | -84.8 Thousand | -50.76 Thousand | -126.09 Thousand |
| Debt repayment | -91.29 Thousand | -60.94 Thousand | -344.98 Thousand | -84.8 Thousand | -50.76 Thousand | -126.09 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -494.85 Thousand | - | - | - | - | - |
| Common Stock Issuance | 147.00 | 2.07 Million | - | -6.02 Billion | 6.02 Billion | - |
| Other Financing Activities | 495 Thousand | 102.62 Million | -344.98 Thousand | 6.02 Billion | -50.76 Thousand | -126.09 Thousand |
| Accounts receivables | -472.01 Thousand | -311.93 Thousand | 311.36 Thousand | 239.52 Thousand | -64.72 Thousand | -79.2 Thousand |
| Accounts payables | 464.1 Thousand | -220.79 Thousand | -14.5 Thousand | -421.33 Thousand | 577.47 Thousand | 27.86 Thousand |
| Inventory | -20.28 Thousand | 8997.00 | -12.94 Thousand | -8576.00 | 193.00 | 1234.00 |
| Other working capital | 168.77 Thousand | -293.77 Thousand | 616.86 Thousand | 563.95 Thousand | 1413.00 | 238.52 Thousand |
| Cash at beginning of period | 2.45 Million | 2.82 Million | 11.41 Million | 4.5 Million | 8.27 Million | 9.76 Million |
| Cash at end of period | 801.31 Thousand | 2.45 Million | 2.82 Million | 2.82 Million | 4.5 Million | 8.27 Million |
| Capital Expenditure | -28.28 Thousand | -41.38 Thousand | -22.9 Thousand | 13.44 Thousand | -169.00 | -3861.00 |
| Effect of forex changes on cash | - | - | 10.00 | -1.36 Billion | 1.19 Billion | 171.74 Million |
| Net cash flow / Change in cash | -1.65 Million | -368.4 Thousand | -8.59 Million | -1.68 Million | -3.76 Million | -1.48 Million |
| Free Cash Flow | -1.56 Million | -2.38 Million | -6.06 Million | -1.6 Million | -1.53 Million | -1.36 Million |
0IRF
AVNW
MIR
TXRH
IPCO
001520